首页|艾司氯胺酮术后镇痛对宫颈癌术后免疫功能及早期焦虑抑郁状态的影响

艾司氯胺酮术后镇痛对宫颈癌术后免疫功能及早期焦虑抑郁状态的影响

扫码查看
目的 探讨艾司氯胺酮对腹腔镜宫颈癌根治术患者的术后镇痛效果,免疫功能及术后早期焦虑抑郁状态的影响.方法 选取 2021 年 12 月至 2022 年 10 月拟择期行腹腔镜宫颈癌根治术患者 60 例,采用随机数字表法分为2 组.观察组术后镇痛采用舒芬太尼 1 μg/kg+艾司氯胺酮 1 mg/kg,对照组采用舒芬太尼 2 μg/kg 患者自控镇痛.比较 2 组患者术后 4 h(T1)、12 h(T2)、24 h(T3)及 48 h(T4)疼痛程度NRS评分和不良反应;ELISA法测定麻醉前30 min、术后 24h及48h血清IFN-γ、IL-4及IFN-γ/IL-4,比较2 组患者于术前1d,术后第3d焦虑自评量表(SAS)和患者抑郁自评量表(SDS).结果 2 组患者术后各时间点NRS评分差异无统计学意义(P>0.05),观察组术后PONV发生率低于对照组(P<0.05);与T0 相比,观察组术后 24h血清IFN-γ水平与IFN-γ/IL-4比值下降,而血清IL-4水平升高(P<0.05);而且术后48h血清血清IFN-γ水平与IFN-γ/IL-4比值与基线水平相似(P>0.05).与对照组相比,观察组在术后 24h和 48h血清IFN-γ水平与IFN-γ/IL-4比值增高,而术后 24h时IL-4水平降低(P<0.05).术后第 3天观察组患者SAS评分和SDS评分均高与术前第 1 天(P<0.05);而对照组术后第 3 天仅SAS评分高于术前(P<0.05);术后第 3 天观察组的SAS评分和SDS评分均低于对照组(P<0.05).结论 艾司氯胺酮用于宫颈癌患者术后静脉自控镇痛,可以有效的缓解术后疼痛,调节炎性因子释放,从而改善术后免疫功能,并且有效改善术后早期焦虑抑郁状态.
Effects of esketamine for postoperative analgesia on postoperative immune function and early-stage anxiety and depression in patients with cervical cancer
Objective To investigate the effects of esketamine on postoperative analgesia,immune function and early-stage postoperative anxiety and depression in patients undergoing laparoscopic radical cervical cancer surgery.Methods Sixty patients treated with elective laparoscopic radical cervical cancer surgery from December 2021 to October 2022 were included.They were randomly divided into the observation group and control group by computer random number table.Patients in the observation group were given intravenous 1mg/kg esketamine combined with 1μg/kg sufentanil for postoperative controlled analgesia,and those in the control group were given 2μg/kg sufentanil for postoperative controlled analgesia.The pain degree assessed by the Numerical Rating Scale(NRS)at 4h(T1),12h(T2),24h(T3)and 48h(T4)postoperatively,and the adverse events were compared between the two groups.Serum levels of interferon-gamma(IFN-γ),interleukin-4(IL-4)and the IFN-γ/IL-4 ratio were measured at 30min before induction,T3 and T4 by ELISA.The Self-Rating Anxiety Scale(SAS)and the Self-Rating Depression Scale(SDS)scores at 1d preoperatively and 3 d postoperatively were compared between groups.Results There was no significant difference in the NRS score at each time point between groups(P>0.05).The incidence of postoperative nausea and vomiting(PONV)in the observation group was significantly lower than that of the control group(P<0.05).Compared with those at T0,serum levels of IFN-γ and IFN-γ/IL-4 ratio significantly decreased at T3,and IL-4 significantly increased in the observation group(P<0.05).Moreover,serum IFN-γ level and IFN-γ/IL-4 ratio at T4 in the observation group were similar to the baseline levels(P>0.05).Serum levels of IFN-γ and the IFN-γ/IL-4 ratio at T3 and T4 in the observation group were significantly higher compared with those of the control group,while serum IL-4 at T3 was significantly lower(P<0.05).The SAS and SDS scores at 3d postoperatively in the observation group were significantly higher than those at 1d preoperatively(P<0.05).In the control group,only the SAS score at 3 d postoperatively was significantly higher than that at 1 d preoperatively(P<0.05).The SAS and SDS scores of the observation group at 3 d postoperatively were significantly lower than those of the control group(P<0.05).Conclusion Esketamine can effectively relieve postoperative pain,regulate the release of inflammatory factors,improve postoperative immune function and effectively alleviate early-stage postoperative anxiety and depression of patients with cervical cancer.

cancercerviximmunityanxietyesketamine

刘正来、敖利、宋建敏、白耀武、张俊丽

展开 >

063000 河北省唐山市妇幼保健院

肿瘤 宫颈 免疫 焦虑 艾司氨胺酮

河北省医学科学研究课题

20221752

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(4)
  • 24